| 1 |
Sonneville R, Dangayach NS, Newcombe V. Neurological complications of critically ill COVID-19 patients. Curr Opin Crit Care 2023;29:61-7. [PMID: 36880556 DOI: 10.1097/MCC.0000000000001029] [Reference Citation Analysis]
|
| 2 |
Lennol MP, Ashton NJ, Moreno-Pérez O, García-Ayllón MS, Ramos-Rincon JM, Andrés M, León-Ramírez JM, Boix V, Gil J, Blennow K, Merino E, Zetterberg H, Sáez-Valero J. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes. Int J Mol Sci 2023;24. [PMID: 36769057 DOI: 10.3390/ijms24032715] [Reference Citation Analysis]
|
| 3 |
Crook H, Ramirez A, Hosseini AA, Vavougyios G, Lehmann C, Bruchfeld J, Schneider A, d'Avossa G, Lo Re V, Salmoiraghi A, Mukaetova-Ladinska E, Katshu M, Boneschi FM, Håkansson K, Geerlings M, Pracht E, Ruiz A, Jansen JF, Snyder H, Kivipelto M, Edison P. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Brain Connect 2023. [PMID: 36719785 DOI: 10.1089/brain.2022.0058] [Reference Citation Analysis]
|
| 4 |
Zhang Q, Fan W, Sun J, Zhang J, Yin Y. Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy. J Inflamm Res 2023;16:161-8. [PMID: 36660377 DOI: 10.2147/JIR.S391325] [Reference Citation Analysis]
|
| 5 |
Sahin BE, Celikbilek A, Kocak Y, Ilanbey B, Saltoglu GT, Konar NM, Hizmali L. Neurological symptoms and neuronal damage markers in acute COVID-19: Is there a correlation? A pilot study. J Med Virol 2023;95:e28240. [PMID: 36262025 DOI: 10.1002/jmv.28240] [Reference Citation Analysis]
|
| 6 |
Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier ER. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 2022;13:1070379. [PMID: 36591311 DOI: 10.3389/fimmu.2022.1070379] [Reference Citation Analysis]
|
| 7 |
Plantone D, Locci S, Bergantini L, Manco C, Cortese R, Meocci M, Cavallaro D, d'Alessandro M, Bargagli E, De Stefano N. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J Neurol Neurosurg Psychiatry 2022;93:1343-8. [PMID: 36137741 DOI: 10.1136/jnnp-2022-329933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Needham EJ, Ren AL, Digby RJ, Norton EJ, Ebrahimi S, Outtrim JG, Chatfield DA, Manktelow AE, Leibowitz MM, Newcombe VFJ, Doffinger R, Barcenas-Morales G, Fonseca C, Taussig MJ, Burnstein RM, Samanta RJ, Dunai C, Sithole N, Ashton NJ, Zetterberg H, Gisslén M, Edén A, Marklund E, Openshaw PJM, Dunning J, Griffiths MJ, Cavanagh J, Breen G, Irani SR, Elmer A, Kingston N, Summers C, Bradley JR, Taams LS, Michael BD, Bullmore ET, Smith KGC, Lyons PA, Coles AJ, Menon DK; Cambridge NeuroCOVID Group, CITIID-NIHR COVID-19 BioResource Collaboration, Cambridge NIHR Clinical Research Facility. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain 2022;145:4097-107. [PMID: 36065116 DOI: 10.1093/brain/awac321] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Erben Y, Prudencio M, Marquez CP, Jansen-West KR, Heckman MG, White LJ, Dunmore JA, Cook CN, Lilley MT, Qosja N, Song Y, Hanna Al Shaikh R, Daughrity LM, Bartfield JL, Day GS, Oskarsson B, Nicholson KA, Wszolek ZK, Hoyne JB, Gendron TF, Meschia JF, Petrucelli L. Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19. iScience 2022;25:105272. [PMID: 36213006 DOI: 10.1016/j.isci.2022.105272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
de Boni L, Odainic A, Gancarczyk N, Kaluza L, Strassburg CP, Kersting XAK, Johnson JM, Wüllner U, Schmidt SV, Nattermann J, Petzold GC. No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache. Neurol Res Pract 2022;4:53. [DOI: 10.1186/s42466-022-00217-5] [Reference Citation Analysis]
|
| 11 |
Alvarez M, Trent E, Goncalves BDS, Pereira DG, Puri R, Frazier NA, Sodhi K, Pillai SS. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci 2022;14:1020092. [DOI: 10.3389/fnagi.2022.1020092] [Reference Citation Analysis]
|
| 12 |
Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier E. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.. [DOI: 10.1101/2022.09.26.22280358] [Reference Citation Analysis]
|
| 13 |
Abu-Rumeileh S, Abdelhak A, Foschi M, D'Anna L, Russo M, Steinacker P, Kuhle J, Tumani H, Blennow K, Otto M. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain 2023;146:421-37. [PMID: 36083979 DOI: 10.1093/brain/awac328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Golota AS, Vologzhanin DA, Kamilova TA, Sсherbak SG, Makarenko SV. NEUROLOGICAL MANIFESTATIONS IN PATIENTS WITH NEW CORONAVIRUS INFECTION COVID-19. Physical and rehabilitation medicine, medical rehabilitation 2022. [DOI: 10.36425/rehab109952] [Reference Citation Analysis]
|
| 15 |
Zingaropoli MA, Iannetta M, Piermatteo L, Pasculli P, Latronico T, Mazzuti L, Campogiani L, Duca L, Ferraguti G, De Michele M, Galardo G, Pugliese F, Antonelli G, Andreoni M, Sarmati L, Lichtner M, Turriziani O, Ceccherini-silberstein F, Liuzzi GM, Mastroianni CM, Ciardi MR. Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients. Cells 2022;11:2480. [DOI: 10.3390/cells11162480] [Reference Citation Analysis]
|
| 16 |
Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA, Cleland JL, Robinson K, McCullough LD, Ng DK, Kannan RM, Kannan S. Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Sci Transl Med 2022;14:eabo2652. [PMID: 35857827 DOI: 10.1126/scitranslmed.abo2652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 17 |
Verde F, Milone I, Bulgarelli I, Peverelli S, Colombrita C, Maranzano A, Calcagno N, Ticozzi N, Perego GB, Parati G, Torresani E, Ratti A, Silani V. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J Neurol 2022. [PMID: 35781535 DOI: 10.1007/s00415-022-11233-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Smeele PJ, Vermunt L, Blok S, Duitman JW, van Agtmael M, Algera AG, Appelman B, van Baarle F, Bax D, Beudel M, Bogaard HJ, Bomers M, Bonta P, Bos L, Botta M, de Brabander J, de Bree G, de Bruin S, Buis DT, Bugiani M, Bulle E, Chekrouni N, Chouchane O, Cloherty A, Dijkstra M, Dongelmans DA, Duijvelaar E, Dujardin RW, Elbers P, Fleuren L, Geerlings S, Geijtenbeek T, Girbes A, Goorhuis B, Grobusch MP, Hafkamp F, Hagens L, Hamann J, Harris V, Hemke R, Hermans SM, Heunks L, Hollmann M, Horn J, Hovius JW, de Jong MD, Koning R, Lim EH, van Mourik N, Nellen J, Nossent EJ, Olie S, Paulus F, Peters E, Pina-fuentes DA, van der Poll T, Preckel B, Raasveld J, Reijnders T, de Rotte MC, Schippers JR, Schinkel M, Schultz MJ, Schrauwen FA, Schuurman A, Schuurmans J, Sigaloff K, Slim MA, Smeele P, Smit M, Stijnis CS, Stilma W, Teunissen C, Thoral P, Tsonas AM, Tuinman PR, van der Valk M, Veelo D, Volleman C, de Vries H, Vught LA, van Vugt M, Wouters D, Zwinderman AH(, Brouwer MC, Wiersinga WJ, Vlaar AP, van de Beek D, Nossent EJ, van Agtmael MA, Heunks LMA, Horn J, Bogaard HJ, Teunissen CE, AmsterdamUMC COVID-19 Biobank. Neurofilament light increases over time in severe COVID-19 and is associated with delirium. Brain Communications 2022;4. [DOI: 10.1093/braincomms/fcac195] [Reference Citation Analysis]
|
| 19 |
Sahin BE, Celikbilek A, Kocak Y, Saltoglu GT, Konar NM, Hizmali L. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci 2022;439:120324. [PMID: 35752131 DOI: 10.1016/j.jns.2022.120324] [Reference Citation Analysis]
|
| 20 |
Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, Greene M, Chow FC, Hellmuth J, Henrich TJ, Glidden DV, Deeks SG. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm 2022;9. [PMID: 35701186 DOI: 10.1212/NXI.0000000000200003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Heimfarth L, Passos FRS, Monteiro BS, Araújo AADS, Quintans Júnior LJ, Quintans JDSS. Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease – A systematic review. International Immunopharmacology 2022;107:108624. [DOI: 10.1016/j.intimp.2022.108624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 22 |
Lingor P, Demleitner AF, Wolff AW, Feneberg E. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t. J Neural Transm. [DOI: 10.1007/s00702-022-02500-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 23 |
Preobrazhenskaya IS. COVID-associated cognitive impairments: A review. Consilium Medicum 2022;24:96-102. [DOI: 10.26442/20751753.2022.2.201512] [Reference Citation Analysis]
|
| 24 |
Hert L, Sutter R. Neurofilament Light Chain in the Blood As Biochemical Markers in the Critically Ill. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_38-1] [Reference Citation Analysis]
|
| 25 |
Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho H, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, Greene M, Chow FC, Hellmuth J, Henrich TJ, Glidden DV, Deeks SG. Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC).. [DOI: 10.1101/2021.11.02.21265778] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Laudanski K, Yakhkind A, Restrepo M, Draham L, Lang AE. Guillain–Barré Syndrome in COVID-19—The Potential Role of NCAM-1 and Immunotherapy. BioMed 2021;1:80-92. [DOI: 10.3390/biomed1010006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Moser T, Seiberl M, Feige J, Bieler L, Radlberger RF, O'Sullivan C, Pilz G, Harrer A, Schwenker K, Haschke-Becher E, Machegger L, Grimm J, Redlberger-Fritz M, Buchmann A, Khalil M, Kvas E, Trinka E, Wipfler P. Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients. Front Immunol 2021;12:718895. [PMID: 34512642 DOI: 10.3389/fimmu.2021.718895] [Reference Citation Analysis]
|
| 28 |
Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, Debure L, Moreira A, Lewis A, Huang J, Thawani S, Balcer L, Galetta S, Wisniewski T. Elevation of Neurodegenerative Serum Biomarkers among Hospitalized COVID-19 Patients.. [DOI: 10.1101/2021.09.01.21262985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Aziz NA, Santos ML, Breteler MM. The association between SARS-CoV-2 infection and neuronal damage: A population-based nested case-control study.. [DOI: 10.1101/2021.09.02.21263019] [Reference Citation Analysis]
|
| 30 |
Mantovani E, Mariotto S, Gabbiani D, Dorelli G, Bozzetti S, Federico A, Zanzoni S, Girelli D, Crisafulli E, Ferrari S, Tamburin S. Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? J Neurovirol 2021. [PMID: 34341960 DOI: 10.1007/s13365-021-01002-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 31 |
Lleó A. Biomarkers in neurological disorders: a fast-growing market. Brain Commun 2021;3:fcab086. [PMID: 33977270 DOI: 10.1093/braincomms/fcab086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
De Lorenzo R, Loré NI, Finardi A, Mandelli A, Cirillo DM, Tresoldi C, Benedetti F, Ciceri F, Rovere-Querini P, Comi G, Filippi M, Manfredi AA, Furlan R. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol 2021. [PMID: 33973106 DOI: 10.1007/s00415-021-10595-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
|
